Digital Learning
White Papers
ICH M10 Guidance: Harmonization and Modification to Bioanalytical Method Variation
Internal Standard (IS) Variation Case Studies: Emerging From Three Common IS Challenges
Metabolite Identification (MetID): A Critical Step in Drug Discovery and Development
Bridging Preclinical and Clinical Assays for Biologics Development –Challenges and Considerations for Phase I Trials
The 2019 FDA Guidance’s Implications for Immunogenicity Assessment
Comparison Between Magnetic Bead and Membrane Immunoaffinity Purification Methods for the Measurement of Monoclonal Antibody in Rat Serum
The BAMA MINIPIG in Toxicology
Service Catalog
Drug Metabolism and Pharmacokinetics
Brochures
Safety Assessment Services
Proteolysis Targeting Chimera
Webinars
DMPK Strategies for Oligonucleotide Therapeutics
Hot Topics and Challenges in Drug Development
Expediting Biologics Drug Development: Strategies to Accelerate Preclinical Development Timelines
DMPK Strategies for Successful Clinical Translation
DMPK Addressing Safety Testing of Drug Metabolites (MIST) in Drug Development
AAPS – The Unique Bioanalytical Needs of New Modalities
ICP-MS
Bioanalysis in Gene and Cell Therapy